JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265468

Human ZDHHC7 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ZDHHC7 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 131 bp insertion in exon 3 and 1 bp insertion in exon 3.

View Alternative Names

DHHC 7, FLJ10792, FLJ20279, Palmitoyltransferase ZDHHC7, ZNF 370, Zinc finger DHHC domain containing 7, Zinc finger DHHC domain containing protein 7, Zinc finger DHHC type containing 7, Zinc finger protein 370

2 Images
Sanger Sequencing - Human ZDHHC7 knockout HeLa cell line (AB265468)
  • Sanger seq

Unknown

Sanger Sequencing - Human ZDHHC7 knockout HeLa cell line (AB265468)

Allele-2 : 131 bp insertion in exon 3.

Sanger Sequencing - Human ZDHHC7 knockout HeLa cell line (AB265468)
  • Sanger seq

Unknown

Sanger Sequencing - Human ZDHHC7 knockout HeLa cell line (AB265468)

Allele-1 : 1 bp insertion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 131 bp insertion in exon 3 and 1 bp insertion in exon 3

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265468-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265468 Human ZDHHC7 knockout HeLa cell line", "number":"AB265468-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265468-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265468 Human ZDHHC7 knockout HeLa cell line", "number":"AB265468-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ZDHHC7
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ZDHHC7 also known as Zinc Finger DHHC-Type Palmitoyltransferase 7 is an enzyme with a molecular mass of approximately 66 kDa. This protein plays an important role in the palmitoylation process which involves attaching palmitic acid to cysteine residues of target proteins. ZDHHC7 is widely expressed in various tissues including neurons liver and heart highlighting its importance in different physiological processes. This protein acts by facilitating the transfer of palmitate to substrates which can influence their localization and stability within cells.
Biological function summary

Zinc Finger DHHC-Type Palmitoyltransferase 7 influences cell signaling and membrane trafficking. It is part of a multi-protein complex that ensures the accurate delivery of proteins to cellular membranes where they perform specific functions. ZDHHC7 modifies signaling molecules impacting pathways related to growth and development. The lipid modification of proteins by ZDHHC7 can also affect cellular communication contributing to the regulation of signal transduction and vesicular transport across different cell types.

Pathways

ZDHHC7 participates in the palmitoylation pathway which is essential for the membrane association and function of many signaling proteins. The Hedgehog signaling pathway is one significant pathway where ZDHHC7 exerts its influence modulating the activity of proteins like Shh. ZDHHC7-related palmitoylation affects the Ras family of GTPases which are vital players in cell proliferation and differentiation. This activity fosters dynamic changes in the cell membrane composition aligning with various cellular reactiveness in response to environmental cues.

Abnormalities in ZDHHC7 function have been linked to Huntington's disease and cancer. Disruptions in its palmitoylation activity can lead to the mislocalization and dysfunction of proteins that are critical for neural stability and cell cycle regulation. In Huntington's disease ZDHHC7 interacts with mutant huntingtin protein which alters its normal palmitoylation pattern. In cancer abnormal ZDHHC7 expression affects proteins like oncogenic Ras enhancing oncogenesis. Understanding these interactions offers avenues for potential therapeutic strategies targeting the aberrant activity of these proteins in diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com